299 related articles for article (PubMed ID: 38282024)
1. NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport.
Yang S; Niou ZX; Enriquez A; LaMar J; Huang JY; Ling K; Jafar-Nejad P; Gilley J; Coleman MP; Tennessen JM; Rangaraju V; Lu HC
Mol Neurodegener; 2024 Jan; 19(1):13. PubMed ID: 38282024
[TBL] [Abstract][Full Text] [Related]
2. NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport.
Yang S; Niou ZX; Enriquez A; LaMar J; Huang JY; Ling K; Jafar-Nejad P; Gilley J; Coleman MP; Tennessen JM; Rangaraju V; Lu HC
Res Sq; 2023 May; ():. PubMed ID: 37292715
[TBL] [Abstract][Full Text] [Related]
3. The chemical biology of NAD
Icso JD; Thompson PR
Curr Opin Chem Biol; 2022 Aug; 69():102176. PubMed ID: 35780654
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
[TBL] [Abstract][Full Text] [Related]
5. MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2.
Walker LJ; Summers DW; Sasaki Y; Brace EJ; Milbrandt J; DiAntonio A
Elife; 2017 Jan; 6():. PubMed ID: 28095293
[TBL] [Abstract][Full Text] [Related]
6. SARM1 is a metabolic sensor activated by an increased NMN/NAD
Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
[TBL] [Abstract][Full Text] [Related]
7. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.
Gilley J; Orsomando G; Nascimento-Ferreira I; Coleman MP
Cell Rep; 2015 Mar; 10(12):1974-81. PubMed ID: 25818290
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons.
Alexandris AS; Ryu J; Rajbhandari L; Harlan R; McKenney J; Wang Y; Aja S; Graham D; Venkatesan A; Koliatsos VE
Neurobiol Dis; 2022 Sep; 171():105808. PubMed ID: 35779777
[TBL] [Abstract][Full Text] [Related]
9. Primary Traumatic Axonopathy in Mice Subjected to Impact Acceleration: A Reappraisal of Pathology and Mechanisms with High-Resolution Anatomical Methods.
Ziogas NK; Koliatsos VE
J Neurosci; 2018 Apr; 38(16):4031-4047. PubMed ID: 29567804
[TBL] [Abstract][Full Text] [Related]
10. Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection.
Sasaki Y; Zhu J; Shi Y; Gu W; Kobe B; Ve T; DiAntonio A; Milbrandt J
Exp Neurol; 2021 Nov; 345():113842. PubMed ID: 34403688
[TBL] [Abstract][Full Text] [Related]
11. Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.
Gerdts J; Summers DW; Milbrandt J; DiAntonio A
Neuron; 2016 Feb; 89(3):449-60. PubMed ID: 26844829
[TBL] [Abstract][Full Text] [Related]
12. Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence.
Lukacs M; Gilley J; Zhu Y; Orsomando G; Angeletti C; Liu J; Yang X; Park J; Hopkin RJ; Coleman MP; Zhai RG; Stottmann RW
Exp Neurol; 2019 Oct; 320():112961. PubMed ID: 31136762
[TBL] [Abstract][Full Text] [Related]
13. The SARM1 axon degeneration pathway: control of the NAD
Figley MD; DiAntonio A
Curr Opin Neurobiol; 2020 Aug; 63():59-66. PubMed ID: 32311648
[TBL] [Abstract][Full Text] [Related]
14. NMNAT2: An important metabolic enzyme affecting the disease progression.
Li W; Gao M; Hu C; Chen X; Zhou Y
Biomed Pharmacother; 2023 Feb; 158():114143. PubMed ID: 36528916
[TBL] [Abstract][Full Text] [Related]
15. An Atypical SCF-like Ubiquitin Ligase Complex Promotes Wallerian Degeneration through Regulation of Axonal Nmnat2.
Yamagishi Y; Tessier-Lavigne M
Cell Rep; 2016 Oct; 17(3):774-782. PubMed ID: 27732853
[TBL] [Abstract][Full Text] [Related]
16. Palmitoylation enables MAPK-dependent proteostasis of axon survival factors.
Summers DW; Milbrandt J; DiAntonio A
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8746-E8754. PubMed ID: 30150401
[TBL] [Abstract][Full Text] [Related]
17. STAT1/3 signaling suppresses axon degeneration and neuronal cell death through regulation of NAD
Murata H; Yasui Y; Oiso K; Ochi T; Tomonobu N; Yamamoto KI; Kinoshita R; Sakaguchi M
Cell Signal; 2023 Aug; 108():110717. PubMed ID: 37187216
[TBL] [Abstract][Full Text] [Related]
18. Axonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo.
Milde S; Gilley J; Coleman MP
Bioarchitecture; 2013; 3(5):133-40. PubMed ID: 24284888
[TBL] [Abstract][Full Text] [Related]
19. DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration.
Summers DW; Frey E; Walker LJ; Milbrandt J; DiAntonio A
Mol Neurobiol; 2020 Feb; 57(2):1146-1158. PubMed ID: 31696428
[TBL] [Abstract][Full Text] [Related]
20. NAD
Alexandris AS; Koliatsos VE
Antioxid Redox Signal; 2023 Dec; 39(16-18):1167-1184. PubMed ID: 37503611
[No Abstract] [Full Text] [Related]
[Next] [New Search]